Announcement, Our Impact 09.22.22 Share on Twitter Share on Facebook Share on LinkedIn Parker Institute Researchers Highlighted at CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference #CICON22 Parker Institute for Cancer Immunotherapy investigators will present the latest findings in immuno-oncology research at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference (#CICON22), Sept. 28-Oct. 1 in New York. The conference focuses on “Translating Science into Survival” and features pre-clinical and clinical research from top immunotherapy scientists in the U.S. and Europe. Topics include T-cell failure, tumor vaccination and the tumor microenvironment. The event is organized by the Cancer Research Institute (CRI), European Network for Cancer Immunotherapy (ENCI) and American Association for Cancer Research (AACR). Two Parker Institute members are conference co-chairs this year: John Wherry, PhD, (Twitter: @EJohnWherry) of the University of Pennsylvania Jedd Wolchok, MD, PhD, (Twitter: @wolchokj) of Weill Cornell Medicine PICI Network researchers James Allison, PhD, (Twitter: @JimAllisonPhD) of The University of Texas MD Anderson Cancer Center and Carl June, MD, (Twitter: @carlhjune) of the University of Pennsylvania are two of the nine members of the scientific planning committee. PICI Network researcher Crystal Mackall, MD, (Twitter: @MackallLab) of Stanford Medicine will deliver the keynote address, “Expanding the reach of CAR T cell therapy for cancer,” Sept. 28 at 8:15 a.m. Eastern. Below are other select sessions featuring Parker Institute investigators. Please note that all events listed are subject to change. For the most current information, visit the event program. Follow the meeting live on Twitter using the hashtag #CICON22. Sept. 28 Session 1: T Cell Failure in Cancer Immunotherapy Session Chair: Andrea Schietinger, PhD, (Twitter: @SchietingerLab), Memorial Sloan Kettering Cancer Center 9 a.m. Eastern Presenter: Andrea Schietinger, PhD Title: CD8 T cell fate decisions in cancer and autoimmunity Presenter: Ansuman Satpathy, MD, PhD, (Twitter: @Satpathology), Stanford Medicine Title: High-throughput genomics in cancer immunotherapy Session 2: Yin and Yang of Tumor Microenvironment (part 1): Suppressing Antitumor Response 2:30 p.m. Eastern Presenter: Santosh Vardhana, MD, PhD, (Twitter: @SantoshVardhana), Memorial Sloan Kettering Cancer Center Title: Context-dependent regulation of T-cell exhaustion by extracellular nutrient availability Sept. 29 Session 5: Moderated Debate: Utility of Preclinical Models 4:30 p.m. Eastern Presenter: Padmanee Sharma, MD, PhD, (Twitter: @PamSharmaMDPhD), The University of Texas MD Anderson Cancer Center Title: From the clinic to the lab: Investigating mechanisms of response and resistance to immune checkpoint therapy Presenter: Dmitriy Zamarin, MD, PhD, (Twitter: @DmitriyZamarin), Memorial Sloan Kettering Cancer Center Title: Modeling immune response in ovarian cancer: opportunities and challenges Sept. 30 Session 6: Cellular Therapies: Engineering T cells Session Chair: Yvonne Chen, PhD, University of California, Los Angeles 8:30 a.m. Eastern Presenter: Christopher Klebanoff, MD (Twitter: @KlebanoffLab), Memorial Sloan Kettering Cancer Center Title: Immunogenic and therapeutic landscape of NRAS 61 public neoantigens Presenter: Yvonne Chen, PhD, University of California, Los Angeles Title: Engineering next-generation CAR-T cells for cancer immunotherapy Presenter: Avery Posey, PhD, (Twitter: @IAmDrDex) University of Pennsylvania Title: Enhancing CAR T cell specificity and activity Presenter: Justin Eyquem, PhD, (Twitter: @j_eyquem) University of California, San Francisco (UCSF) Title: To be announced Session 7: Embracing the Host Ecosystem or Ecology: Immune Health and Fitness Session Chair: John Wherry, PhD, University of Pennsylvania 2 p.m. Eastern Presenter: Matthew Spitzer, PhD, (Twitter: @SpitzerLab) University of California, San Francisco, Gladstone-UCSF Institute for Genomic Immunology Title: Systemic impacts of cancer on immune function Oct. 1 Session 8: Barriers and Opportunities for Tumor Vaccination 8 a.m. Eastern Presenter: Vinod Balachandran, MD (Twitter: @TheVinodLab), Memorial Sloan Kettering Cancer Center Topic: Individualized mRNA neoantigen vaccines for pancreatic cancer Session 9: Spatial, Temporal and Computational Approaches for Understanding Tumor Immunity Session Chair: Robert Schreiber, PhD, Washington University School of Medicine in St. Louis 10:30 a.m. Eastern Presenter: Robert Schreiber, PhD Topic: Spatial-proteomics analysis of successful cancer immunotherapy in a mouse cancer model Related Announcement, Press Release PICI’s 2024 Fall Scientific Retreat Ignites Collaboration to Accelerate Cancer Immunotherapy Announcement, Press Release Parker Institute Welcomes New Co-Directors for PICI Centers at Stanford, UCSF & Penn Announcement, Press Release Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer
Announcement, Press Release PICI’s 2024 Fall Scientific Retreat Ignites Collaboration to Accelerate Cancer Immunotherapy
Announcement, Press Release Parker Institute Welcomes New Co-Directors for PICI Centers at Stanford, UCSF & Penn
Announcement, Press Release Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer